Rabbit anti-Human p73 Polyclonal Antibody | anti-p73 antibody

p73, aa450-636 (MaxLight 650)

Cat. Num. AAA6491589

• Gene Names: TP73; P73
• Reactivity: Human
• Applications: Immunohistochemistry, Western Blot, Immunoprecipitation
• Purity: > 95% (SDS-PAGE). Purified by affinity chromatography and 0.22um filtered.
• Synonyms: p73; Polyclonal Antibody; aa450-636 (MaxLight 650); anti-p73 antibody

• Host: Rabbit
• Reactivity: Human
• Clonality: Polyclonal
• Isotype: IgG
• Specificity: Recognizes amino acids 450-636 of human p73 protein. This region is common to both p73 alpha and p73 beta isoforms, hence both isoforms of the p73 protein will be detected.
• Purity/Purification: > 95% (SDS-PAGE). Purified by affinity chromatography and 0.22um filtered.
• Form/Format: Supplied as a liquid in PBS, pH 7.2. No preservative added. Labeled with MaxLight650.

• Applicable Applications for anti-p73 antibody: Immunohistochemistry (IHC), Western Blot (WB), Immunoprecipitation (IP)
• Application Notes: IHC: It may be necessary to incorporate a signal amplification technique in conjunction with standard procedures.; WB: 1ug/ml of the antibody will detect p73 in 30ug of total cell lysate from overexpressing cell lines. Higher levels of antibody may be necessary when using native tissue sources.; Applications are based on unconjugated antibody.
• Immunogen: GST fusion protein that contains aa450-636 of the p73 protein.
• Conjugate: MaxLight650
• Note: Preservative Free
• Preparation and Storage: Store product at 4 degree C in the dark. DO NOT FREEZE! Stable at 4 degree C for 12 months after receipt as an undiluted liquid. Dilute required amount only prior to immediate use. Further dilutions can be made in assay buffer. Caution: MaxLight650 conjugates are sensitive to light. For maximum recovery of product, centrifuge the original vial prior to removing the cap.

Testing Data

(Detection of p73 expressing cells in ovarian tumor section, usingMBS643478. Slide reproduced with kind permission of Dr Kum Kum Khana, Oncology Unit, Queensland Institute of Medical Research, Brisbane, Australia.)

Product Categories/Family for anti-p73 antibody

Antibodies; Transcription Factors

References

1. Jost, C., et al. (197) Nature 389: 191. 2. Kaghad, M., et al. (1997). Cell 90: 809-819.

NCBI and Uniprot Product Information

• NCBI GI #: 187828902
• NCBI GeneID: 7161
• NCBI Accession #: NP_001119712.1
• NCBI GenBank Nucleotide #: NM_005427.1
• UniProt Accession #: O15350; O15351; Q17RN8; Q5TBV5; Q5TBV6; Q8NHW9; Q8TDY5; Q8TDY6; Q9NTK8; B7Z7J4; B7Z9C1
• Molecular Weight: 69,623 Da
• NCBI Official Full Name: tumor protein p73 isoform b
• NCBI Official Synonym Full Names: tumor protein p73
• NCBI Official Symbol: TP73
• NCBI Official Synonym Symbols: P73
• NCBI Protein Information: tumor protein p73; p53-related protein; p53-like transcription factor
• UniProt Protein Name: Tumor protein p73
• UniProt Gene Name: TP73
• UniProt Synonym Gene Names: P73
• UniProt Entry Name: P73_HUMAN

NCBI Description

This gene encodes a member of the p53 family of transcription factors involved in cellular responses to stress and development. It maps to a region on chromosome 1p36 that is frequently deleted in neuroblastoma and other tumors, and thought to contain multiple tumor suppressor genes. The demonstration that this gene is monoallelically expressed (likely from the maternal allele), supports the notion that it is a candidate gene for neuroblastoma. Many transcript variants resulting from alternative splicing and/or use of alternate promoters have been found for this gene, but the biological validity and the full-length nature of some variants have not been determined. [provided by RefSeq, Feb 2011]

Uniprot Description

p73: a protein of the p53 family of proteins. p73, like p53, may have tumor suppressor activity, but its multiple isoforms possess different and sometimes opposing functions. Participates in the apoptotic response to DNA damage. Phosphorylated in a cell cycle-dependent manner and negatively regulated by CDKs. When overproduced, activates transcription from p53-responsive promoters and induces apoptosis. Nine transactivation competent (TA) or dominant negative (DN) isoforms, derived from alternative-splicing and alternative promoters, have been described. NH2-terminally truncated p73 isoforms (DNp73) may be oncogenic. DNp73 is elevated in a number of cancers and is associated with adverse clinical outcomes and resistance to chemotherapy. The C-terminal oligomerization domain binds to the ABL1 tyrosine kinase SH3 domain. Isoform Beta interacts homotypically and with p53/TP53, whereas isoform Alpha does not. Isoform Gamma interacts homotypically and with all p73 isoforms. Isoform Delta interacts with isoform Gamma, isoform Alpha, and homotypically. Isoforms Alpha and Beta interact with HIPK2. Isoform Alpha interacts with RANBP9; forms complex with p53 and CABLES1. Isoform Beta interacts with WWOX; interacts with HECW2.

Protein type: Tumor suppressor; DNA-binding; Transcription factor

Chromosomal Location of Human Ortholog: 1p36.3

Cellular Component: nucleoplasm; Golgi apparatus; transcription factor complex; intracellular membrane-bound organelle; cell junction; chromatin; cytosol; nucleus

Molecular Function: identical protein binding; protein binding; p53 binding; metal ion binding; double-stranded DNA binding; damaged DNA binding; chromatin binding; transcription factor activity; transcription factor binding; protein kinase binding

Biological Process: transcription from RNA polymerase II promoter; G1 DNA damage checkpoint; cerebrospinal fluid secretion; positive regulation of cell size; activation of MAPK activity; positive regulation of transcription, DNA-dependent; regulation of mitotic cell cycle; negative regulation of transcription from RNA polymerase II promoter; post-embryonic development; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; negative regulation of cardiac muscle cell proliferation; response to gamma radiation; positive regulation of oligodendrocyte differentiation; negative regulation of neuron apoptosis; cell cycle arrest; kidney development; inflammatory response; DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis; protein tetramerization; response to X-ray; negative regulation of JNK activity; release of cytochrome c from mitochondria; mismatch repair; hippocampus development; digestive tract morphogenesis; response to organic nitrogen; negative regulation of neuron differentiation; DNA damage response, signal transduction resulting in induction of apoptosis; regulation of gene expression; neuron development; positive regulation of transcription from RNA polymerase II promoter; response to DNA damage stimulus